Romain Duroux
Toulouse, 31036, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Novel Quinazoline Derivatives as Highly Effective A2A Adenosine Receptor Antagonists.
Journal: Molecules (Basel, Switzerland)
Published: July 11, 2024
Predicting Chronological Age via the Skin Volatile Profile.
Journal: Journal of the American Society for Mass Spectrometry
Published: February 07, 2024
An upcycled fraction of Melaleuca alternifolia essential oil regenerates the skin through the skin melatonin pathway and improves sleep quality.
Journal: Journal of cosmetic dermatology
Published: May 05, 2023
Targeting inflammation and pro-resolving mediators with Anetholea anisita extract to improve scalp condition.
Journal: International journal of cosmetic science
Published: May 09, 2022
High ligand efficiency quinazoline compounds as novel A2A adenosine receptor antagonists.
Journal: European journal of medicinal chemistry
Published: January 12, 2022
Adenosine A2A Receptors Are Upregulated in Peripheral Blood Mononuclear Cells from Atrial Fibrillation Patients.
Journal: International journal of molecular sciences
Published: March 06, 2021
A Rose Extract Protects the Skin against Stress Mediators: A Potential Role of Olfactory Receptors.
Journal: Molecules (Basel, Switzerland)
Published: August 28, 2020
Adenosine A1-A2A Receptor-Receptor Interaction: Contribution to Guanosine-Mediated Effects.
Journal: Cells
Published: November 06, 2019
Design and synthesis of 2,6-disubstituted-8-amino imidazo[1,2a]pyridines, a promising privileged structure.
Journal: Bioorganic & medicinal chemistry
Published: March 09, 2018
Bitopic fluorescent antagonists of the A2A adenosine receptor based on pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine functionalized congeners.
Journal: MedChemComm
Published: December 19, 2017
Activation of adenosine A2A or A2B receptors causes hypothermia in mice.
Journal: Neuropharmacology
Published: October 24, 2017
Synthesis and biological evaluation of new naphtho- and quinolinocyclopentane derivatives as potent melatoninergic (MT1/MT2) and serotoninergic (5-HT2C) dual ligands.
Journal: European journal of medicinal chemistry
Published: September 18, 2017
Last Updated: 09/26/2026